Objective: The purpose of the current study is to understand the clinicopathological implications of redox proteins in association with androgen receptor (AR) and HER-2 status in estrogen receptor (ER)-negative breast cancers through evaluation of the expression patterns of redox proteins, such as catalase, thioredoxin reductase (TxNR), glutathione Stransferase p (GSTp), thioredoxin interacting protein (TxNIP), and manganese superoxide dismutase (MnSOD).
Methods: Two hundred cases of ER-negative breast cancer samples were collected as a tissue microarray. Immunohistochemical staining was done for redox-related proteins, after which the resulting data set was organized by AR and HER-2 status.
Results: The redox proteins that had a significant association with AR and HER-2 status were tumoral catalase (p < 0.001) and stromal GSTp (p < 0.001). Tumoral catalase was least expressed in the AR-/HER-2- group, while stromal GSTp was least expressed in both the AR+/HER-2- and the AR-/HER-2- groups. Stromal GSTp was highly expressed in HER-2 positive groups (p < 0.001). Stromal GSTp negativity and tumoral MnSOD positivity were associated with a shorter diseasefree survival (p = 0.041 and p = 0.007, respectively) in univariate analysis.
Conclusion: ER-negative breast cancers showed different expressions of redox-related proteins ac-cording to AR and HER-2 status. Catalase expression was high in AR-negative groups, while stromal GSTp expression was high in HER-2-positive groups.
Bibliographical notePublisher Copyright:
© 2014 S. Karger AG, Basel.
All Science Journal Classification (ASJC) codes
- Pathology and Forensic Medicine
- Molecular Biology
- Cell Biology